Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure

Pironi, LorisSteiger, EzraJoly, FranciscaWanten, Geert J. A.Chambrier, CecileAimasso, UmbertoSasdelli, Anna SimonaSzczepanek, KingaJukes, AmeliaTheilla, MiriamKunecki, MarekDaniels, JoanneSerlie, Mireille J.Cooper, Sheldon C.Poullenot, FlorianRasmussen, Henrik HøjgaardCompher, Charlene W.Crivelli, AdrianaHughes, Sarah-JaneSantarpia, LidiaGuglielmi, Francesco WilliamRotovnik Kozjek, NadaEllegard, LarsSchneider, Stéphane M.Matras, PrzemysławForbes, AlastairWyer, NicolaZmarzly, AnnaTaus, MarinaO'Callaghan, MargieOsland, EmmaThibault, RonanCuerda Compes, María CristinaJones, LynnChapman, BrookeSahin, PeterVirgili, Núria M.Lee, Andre Dong WonOrlandoni, PaoloMatysiak, KonradDi Caro, SimonaDoitchinova Simeonova, MaryanaMasconale, LuisaSpaggiari, CorradoGarde, CarmenSerralde Zúñiga, Aurora E.Olveira, GabrielKrznaric, ZeljkoPetrina Jáuregui, EstrellaZugasti Murillo, AnaSuárez Llanos, José P.Nardi, ElenaVan Gossum, AndréLal, Simon2024-02-022024-02-022020-01-21https://hdl.handle.net/20.500.14352/98228engIntravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failurejournal articleopen accessCiencias Biomédicas32 Ciencias Médicas